Early clinical response in patients with migraine in treatment with anti-CGRP monoclonal antibodies: a possible "loading dose" effect?

被引：0
|
作者：
Ceccardi, Giulia
di Cola, Francesca Schiano
Bolchini, Marco
Di Pasquale, Michele
Rao, Renata
Padovani, Alessandro
机构：
[1] ASST Spedali Civili, Neurol Unit, Brescia, Italy
[2] ASST Spedali Civili, Headache Ctr, Dipartimento Continuita Cura & Fragilita, Brescia, Italy
[3] Univ Brescia, Brescia, Italy
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-PO-2
引用
收藏
页码：253 / 254
页数：2
相关论文
共 50 条
  • [41] Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine
    Ceccardi, Giulia
    di Cola, Francesca Schiano
    Caratozzolo, Salvatore
    Di Pasquale, Michele
    Bolchini, Marco
    Padovani, Alessandro
    Rao, Renata
    TOXINS, 2023, 15 (12)
  • [42] Evaluating the indications for treatment with OnabotulinumtoxinA and anti-CGRP monoclonal antibodies in migraine patients attending a headache outpatient clinic
    Rachao, Augusto
    Silva, Elisa
    Fernandes, Catia
    Pereira, Liliana
    Rodrigues, Miguel
    CEPHALALGIA, 2019, 39 : 270 - 271
  • [43] OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine
    Argyriou, Andreas A. A.
    Dermitzakis, Emmanouil V. V.
    Xiromerisiou, Georgia
    Vikelis, Michail
    TOXINS, 2022, 14 (12)
  • [44] OnabotulinumtoxinA add-on to monoclonal anti-CGRP antibodies in treatment-refractory chronic migraine
    Dermitzakis, E.
    Argyriou, A.
    Xiromerisiou, G.
    Vikelis, M.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [45] Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants
    Do, T. P.
    Al-Saoudi, A.
    Ashina, M.
    REVUE NEUROLOGIQUE, 2021, 177 (07) : 827 - 833
  • [46] Long-term effectiveness of monoclonal anti-CGRP antibodies in patients with migraine in real life
    Perez Prol, C.
    Espinoza Vinces, C.
    Villino Rodriguez, R.
    Atorrasagasti Villar, A.
    Gimeno Rodriguez, M.
    Benitez Martinez, B.
    Beistegui Sarobe, M.
    Sanchez del Rio, M.
    Irimia Sieira, P.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [47] Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study
    Larry Charleston
    Brian Talon
    Christine Sullivan
    Carlton Anderson
    Steven Kymes
    Stephane A. Regnier
    Seema Soni-Brahmbhatt
    Stephanie J. Nahas
    The Journal of Headache and Pain, 24
  • [48] Impact of migraine attack accompanying symptoms in treatment response to anti-CGRP monoclonal antibodies treatment and their evolution after 6 months
    Alpuente, A.
    Torre-Sune, A.
    Caronna, E.
    Torres-Ferrus, M.
    Pozo-Rosich, P.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [49] Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study
    Charleston, Larry
    Talon, Brian
    Sullivan, Christine
    Anderson, Carlton
    Kymes, Steven
    Regnier, Stephane A. A.
    Soni-Brahmbhatt, Seema
    Nahas, Stephanie J. J.
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01):
  • [50] Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
    Piero Barbanti
    Gabriella Egeo
    Cinzia Aurilia
    Claudia Altamura
    Florindo d’Onofrio
    Cinzia Finocchi
    Maria Albanese
    Marco Aguggia
    Renata Rao
    Maurizio Zucco
    Fabio Frediani
    Massimo Filippi
    Roberta Messina
    Sabina Cevoli
    Antonio Carnevale
    Giulia Fiorentini
    Stefano Messina
    Francesco Bono
    Paola Torelli
    Stefania Proietti
    Stefano Bonassi
    Fabrizio Vernieri
    The Journal of Headache and Pain, 2022, 23
12345